Press "Enter" to skip to content

2019 Global Antibody Drug Conjugates (ADCs) Market by Competitive Landscape, Development Trends, Business Strategies, Types, and Applications 2025

Antibody Drug Conjugates (ADCs) Market in

Global Antibody Drug Conjugates (ADCs) Market research report provides in depth analysis of the industry along with important statistics and facts. With the help of this information, stakeholders can plan their business strategies.

Antibody Drug Conjugates (ADCs) are monoclonal antibodies (mAbs) attached to biologically active drugs by chemical linkers with labile bonds. By combining the unique targeting of mAbs with the cancer-killing ability of cytotoxic drugs, ADCs allow sensitive discrimination between healthy and diseased tissue. ADCs are part of a specialized subset of highly potent APIs. This technically challenging type of therapy combines innovations from biotechnology and chemistry to form a new class of highly potent biopharmaceutical drugs.Advances in coupling antibodies to cytotoxic drugs permit greater control of drug pharmacokinetics and significantly improve delivery to target tissue. Potent new anti-cancer drugs can now be used to target cancers while minimizing exposure of healthy tissue.The global Antibody Drug Conjugates (ADCs) market was xx million US$ in 2018 and is expected to xx million US$ by the end of 2025, growing at a CAGR of xx% between 2019 and 2025.

Get Sample PDF of report at:

Global Antibody Drug Conjugates (ADCs) market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including. Based on product, this report displays the production, revenue, price, and market share and growth rate of each type, primarily split into

Antibody Drug Conjugates (ADCs) Market by Applications:

  • Hospital
  • Clinics
  • Others

    Antibody Drug Conjugates (ADCs) Market by Types:

  • Seattle Genetics Technology
  • ImmunoGen Technology
  • Immunomedics Technology

    Major Key Players Profiled in Antibody Drug Conjugates (ADCs) Report are:

  • Roche
  • Pfizer
  • Novartis
  • Genmab
  • Bayer
  • Seattle Genetics
  • Takeda Pharmaceuticals
  • AbbVie
  • AbGenomics
  • ADC Therapeutics
  • Astellas Pharma
  • Kairos Therapeutics

    Have Any Query or Specific Requirement? Ask to Our Industry Expert @

    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Antibody Drug Conjugates (ADCs) for each application, including

    Regions covered in the Antibody Drug Conjugates (ADCs) Market report:

    • North America
    • Europe
    • China
    • Japan
    • Southeast Asia
    • India

    Price of Report (single User Licence): $ 3350

    Purchase this report at:

    Some major points from Table of Content:

    1 Study Coverage

    1.1 Antibody Drug Conjugates (ADCs) Product

    1.2 Key Market Segments in This Study

    1.3 Key Manufacturers Covered

    1.4 Market by Type

    1.5 Market by Application

    2 Executive Summary

    2.1 Global Antibody Drug Conjugates (ADCs) Production

    2.2 Antibody Drug Conjugates (ADCs) Growth Rate (CAGR) 2018-2025

    2.3 Analysis of Competitive Landscape

    2.4 Market Drivers, Trends and Issues

    2.5 Macroscopic Indicator

    4 Antibody Drug Conjugates (ADCs) Production by Regions

    4.1 United States

    4.2 Europe

    4.3 China

    4.4 Japan

    4.5 Other Regions

    6 Market Size by Type

    6.1 Global Antibody Drug Conjugates (ADCs) Breakdown Dada by Type

    6.2 Global Antibody Drug Conjugates (ADCs) Revenue by Type

    6.3 Antibody Drug Conjugates (ADCs) Price by Type

    7 Market Size by Application

    7.1 Overview

    7.2 Global Antibody Drug Conjugates (ADCs) Breakdown Dada by Application

    7.2.1 Global Antibody Drug Conjugates (ADCs) Consumption by Application

    7.2.2 Global Antibody Drug Conjugates (ADCs) Consumption Market Share by Application (2013-2018)

    8 Manufacturers Profiles

    8.1 Company Description

    8.2 Capacity, Production and Value of Antibody Drug Conjugates (ADCs)

    8.3 Antibody Drug Conjugates (ADCs) Product Description


    About Us:

    Absolute Reports is an upscale platform to help key personnel in the business world in strategizing and taking visionary decisions based on facts and figures derived from in depth market research. We are one of the top report resellers in the market, dedicated towards bringing you an ingenious concoction of data parameters.

    Contact Us:

    Name: Ajay More

    Organization: Absolute Reports

    Phone: +1424 253 0807/ +44 203 239 8187

    Mail at: [email protected]

  • Mission News Theme by Compete Themes.